Source: Korea Biomedical Review

Nipro: Precision Biosensor partners with Japan's NIPRO to expand clinical diagnostics market

Korean in-vitro diagnostics company Precision Biosensor has entered a supply agreement with NIPRO Corporation, a Japanese medical device and pharmaceutical company, to expand its presence in the Japanese market with a clinical chemistry product for human use. The agreement, announced Wednesday, runs

Read full article »
Annual Revenue
$1.0-5.0B
Employees
1.0-5.0K
Yoshihiko Sano's photo - President of Nipro

President

Yoshihiko Sano

CEO Approval Rating

80/100

Read more